Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Manonelles

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|February 15, 2022
Molecular Mechanisms of Kidney Injury and RepairSandra Rayego-Mateos, Laura Marquez-Expósito, Raquel Rodrigues-Diez, et al.
Frontiers in Pharmacology|April 5, 2021
Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney TransplantationPere Fontova, Helena Colom, Raül Rigo-Bonnin, et al.
Pharmaceutics|September 27, 2025
Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling StudyZeyar Mohammed Ali, Beatriz Fernández-Alarcón, Pere Fontova, et al.
Frontiers in Immunology|March 29, 2021
Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney TransplantationMaria Meneghini, Elena Crespo, Matthias Niemann, et al.
Kidney Medicine|August 17, 2021
Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma in a Kidney Transplant RecipientEdoardo Melilli, Alberto Mussetti, Gabriela Sanz Linares, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 8, 2018
Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantationSergi Luque, Marc Lúcia, Edoardo Melilli, et al.
Kidney International|June 30, 2023
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian PredictionNuria Lloberas, Josep M Grinyó, Helena Colom, et al.
Clinical Kidney Journal|April 14, 2025
Cancer risks in people on dialysis and kidney transplant recipients: a Catalan cohort study, 2003-21Laia Oliveras, Laura Pareja, Josepa Ribes, et al.
Pharmaceutics|May 27, 2023
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus FormulationsPere Fontova, Lisanne N van Merendonk, Anna Vidal-Alabró, et al.
Therapeutic Drug Monitoring|December 8, 2025
Tacrolimus Conversion in CYP3A5*1 Expressers: From Immediate-Release to LCP FormulationAnna Vidal-Alabró, Pere Fontova, Zeyar Mohammed Ali, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|February 15, 2022
Molecular Mechanisms of Kidney Injury and RepairSandra Rayego-Mateos, Laura Marquez-Expósito, Raquel Rodrigues-Diez, et al.
Frontiers in Pharmacology|April 5, 2021
Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney TransplantationPere Fontova, Helena Colom, Raül Rigo-Bonnin, et al.
Pharmaceutics|September 27, 2025
Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling StudyZeyar Mohammed Ali, Beatriz Fernández-Alarcón, Pere Fontova, et al.
Frontiers in Immunology|March 29, 2021
Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney TransplantationMaria Meneghini, Elena Crespo, Matthias Niemann, et al.
Kidney Medicine|August 17, 2021
Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma in a Kidney Transplant RecipientEdoardo Melilli, Alberto Mussetti, Gabriela Sanz Linares, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 8, 2018
Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantationSergi Luque, Marc Lúcia, Edoardo Melilli, et al.
Kidney International|June 30, 2023
A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian PredictionNuria Lloberas, Josep M Grinyó, Helena Colom, et al.
Clinical Kidney Journal|April 14, 2025
Cancer risks in people on dialysis and kidney transplant recipients: a Catalan cohort study, 2003-21Laia Oliveras, Laura Pareja, Josepa Ribes, et al.
Pharmaceutics|May 27, 2023
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus FormulationsPere Fontova, Lisanne N van Merendonk, Anna Vidal-Alabró, et al.
Therapeutic Drug Monitoring|December 8, 2025
Tacrolimus Conversion in CYP3A5*1 Expressers: From Immediate-Release to LCP FormulationAnna Vidal-Alabró, Pere Fontova, Zeyar Mohammed Ali, et al.
Pageof 6